Work

Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma

Year: 2013

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-013-0054-5

Authors: Ajjai Alva, Stephanie Daignault, David C. Smith, Maha Hussain

Institutions: University of Michigan, U-M Rogel Cancer Center

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Celgene, National Institutes of Health, National Center for Advancing Translational Sciences

Award: Michigan Institute for Clinical and Health Research (MCHR)

OpenAlex ID: W1995397706

FWCI: 0.598

Cites: 28

Cited by: 9

Related to: 10